Viatris Inc (VTRS) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $15.25
• Market Cap: $18.56B
• EPS: $-3.13
• Dividend Yield: 0.03%
• 52-Week High: $16.47
• 52-Week Low: $6.60

Market Sentiment

Viatris Inc currently has a Bullish sentiment score of 0.19.

About Viatris Inc

Viatris Inc. (VTRS) is a prominent global healthcare company headquartered in Canonsburg, Pennsylvania, formed through the strategic merger of Mylan and Upjohn, a division of Pfizer. With a comprehensive portfolio that encompasses generic, branded, and over-the-counter medications, Viatris is dedicated to expanding access to high-quality medicines across more than 165 countries. The company focuses on addressing diverse health challenges and improving patient outcomes through its extensive di...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Viatris Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is VTRS's current dividend yield?

Viatris Inc (VTRS) has a current dividend yield of 0.03%.

Does VTRS pay dividends?

Yes, Viatris Inc pays dividends with a current yield of 0.03%.

What is VTRS's market cap?

Viatris Inc (VTRS) has a market capitalization of $18.56B with a current stock price of $15.25.